We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-10269
ALLERGAN, INC.
(Exact Name of Registrant as Specified in its Charter)
Morris Corporate Center
400 Interpace Parkway
Parsippany, New Jersey 07054
(862) 261-7000
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock ($0.01 par value)
(Title of each class of securities covered by this Form)
N/A
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | x | |
Rule 12g-4(a)(2) | ¨ | |
Rule 12h-3(b)(1)(i) | x | |
Rule 12h-3(b)(1)(ii) | ¨ | |
Rule 15d-6 | ¨ |
Approximate number of holders of record as of the certification or notice date: One*
* | On March 17, 2015, pursuant to the Agreement and Plan of Merger, dated November 16, 2014 among Actavis plc (Actavis), Avocado Acquisition Inc. (Merger Sub) and Allergan, Inc. (the Company), Merger Sub merged with and into the Company, with the Company being the surviving entity (the Merger). As a result of the Merger, the Company became an indirect wholly owned subsidiary of Actavis. |
Pursuant to the requirements of the Securities Exchange Act of 1934, Allergan, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: March 27, 2015 | ALLERGAN, INC. | |||||
By: | /s/ A. Robert D. Bailey | |||||
Name: | A. Robert D. Bailey | |||||
Title: | President and Chairman of the Board |
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions